Some experts fear that recent reforms instated by the Centers for Medicare and Medicaid Services…
View More Dialysis facility closures linked to patient hospitalizations and deaths
Home »
Dimirel
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. DIMIREL® (di-mi-RELL)…
View More Dimirel
Vexazone
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VEXAZONE contains…
View More Vexazone
Eprex
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EPREX® PREFILLED…
View More Eprex
Exforge HCT
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EXFORGE® HCT…
View More Exforge HCT
Kyprolis
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. KYPROLIS® Carfilzomib…
View More Kyprolis
Clinical trials and research priorities in dialysis patients: Time for a new approach?
Patients with end-stage renal disease (ESRD) experience extremely high morbidity and mortality, and there are…
View More Clinical trials and research priorities in dialysis patients: Time for a new approach?